2011 Annual World EAPA Conference
Click here to go to the previous page
Treatment of Substance-Dependent Employees: A Two-Year Seamless Holistic Continuum of Care Model
Track
:
Domain III
Program Code:
1027-1b-030
Date:
Thursday, October 27, 2011
Time:
10:45 AM to 12:15 PM
EST
Location:
Room 402
SPEAKER
(S):
Although he lives with his family in the US, Dr. Toverud is a native of
Norway, he commutes 200 days a year to work in Scandinavia. His specialties are assessment, diagnosis, treatment and aftercare. A scientist practitioner, Dr. Toverud works clinically and pedagogically allowing for integrative clinical and educational synthesis.
|
Kari Croucher is the developer of the current model to be presented. She synthesizes her international business experience with her psychotherapy training in her EAP work with some of Norway s largest companies. She is a dynamic and sought after speaker on the synthesis of multidisciplinary approaches within the work/life dimension.
|
Description
In Norway, as in many countries, treatment for substance dependent employees has been fragmented and inconsistent resulting in productivity loss and/or job termination. Beginning in 2008, employees referred to EAPs by their supervisor began participating in a pilot substance abuse treatment program supported by trade unions, employers, the national government and funded by private insurance agencies. The current program is a combination of the Recovery Dynamics treatment model and the psychosynthetic orientation. This integrative model implemented at all levels of the treatment continuum encourages consistent and comprehensive personal growth resulting in recovery from addiction which in turn increases work productivity.
1) Describe the collaborative efforts of various stakeholders in the development of this model addiction treatment program;
2)Identify validated diagnostic instruments which differentiate between substance abuse and substance dependence;
3) Discuss how a psychosynthetic orientation is thought to achieve greater personal growth and retard relapse.
No items are available for this session.